TY  - JOUR
AU  - Tundidor, Isabel
AU  - Seijo-Vila, Marta
AU  - Blasco-Benito, Sandra
AU  - Rubert-Hernández, María
AU  - Adámez, Sandra
AU  - Andradas, Clara
AU  - Manzano, Sara
AU  - Álvarez-López, Isabel
AU  - Sarasqueta, Cristina
AU  - Villa-Morales, María
AU  - González-Lois, Carmen
AU  - Ramírez-Medina, Esther
AU  - Almoguera, Belén
AU  - Sánchez-López, Antonio J
AU  - Bindila, Laura
AU  - Hamann, Sigrid
AU  - Arnold, Norbert
AU  - Röcken, Christoph
AU  - Heras-Murillo, Ignacio
AU  - Sancho, David
AU  - Moreno-Bueno, Gema
AU  - Caffarel, María M
AU  - Guzmán, Manuel
AU  - Sánchez, Cristina
AU  - Pérez-Gómez, Eduardo
PY  - 2023
DO  - 10.1038/s41467-023-38750-9
UR  - http://hdl.handle.net/20.500.12105/19313
AB  - Clinical management of breast cancer (BC) metastasis remains an unmet need as it accounts for 90% of BC-associated mortality. Although the luminal subtype, which represents >70% of BC cases, is generally associated with a favorable outcome, it is...
LA  - eng
PB  - Nature Publishing Group
KW  - Amidohydrolases
KW  - Biomarkers, Tumor
KW  - Lung Neoplasms
KW  - Animals
KW  - Mice
KW  - Neoplasm Recurrence, Local
TI  - Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer.
TY  - journal article
ER  -